Verition Fund Management LLC Repligen Corp Transaction History

Verition Fund Management LLC

  • $13 Billion
  • Q1 2024

A detailed history of Verition Fund Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 5,375 shares of RGEN stock, worth $677,572. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,375
Previous 1,655 224.77%
Holding current value
$677,572
Previous $297,000 232.66%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$170.78 - $208.42 $635,301 - $775,322
3,720 Added 224.77%
5,375 $988,000
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $34,251 - $55,605
-300 Reduced 15.35%
1,655 $297,000
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $194,292 - $247,114
-1,400 Reduced 41.73%
1,955 $310,000
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $218,149 - $284,168
1,576 Added 88.59%
3,355 $474,000
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $274,428 - $352,419
1,779 New
1,779 $299,000
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $954,178 - $1.52 Million
5,948 New
5,948 $1.11 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $248,071 - $397,000
-1,539 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $381,041 - $468,579
1,539 New
1,539 $408,000
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $439,401 - $731,417
-2,256 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $374,202 - $498,463
2,256 New
2,256 $450,000
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $329,033 - $458,998
-2,222 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$122.51 - $158.27 $272,217 - $351,675
2,222 New
2,222 $328,000

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email